Emanuel Haasbach

NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients

Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger et al. · Frontiers in Immunology · 2020 · 209 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Immunology +24

Influenza Virus Infection Aggravates Stroke Outcome

Sajjad Muhammad, Emanuel Haasbach, Maria Kotchourko et al. · Stroke · 2011 · 117 citations · Full text

The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance

Christina Ehrhardt, Andrea Rückle, Eike R. Hrincius et al. · Cellular Microbiology · 2013 · 83 citations

Immunology, Viral Pathogenesis, Nf-κb Inhibitor Sc75741 +21

The NS1 Protein of Influenza A Virus Blocks RIG-I-Mediated Activation of the Noncanonical NF-κB Pathway and p52/RelB-Dependent Gene Expression in Lung Epithelial Cells

Andrea Rückle, Emanuel Haasbach, Ilkka Julkunen et al. · Journal of Virology · 2012 · 63 citations · Full text

Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro

Emanuel Haasbach, Carmen Hartmayer, Oliver Planz · Antiviral Research · 2013 · 58 citations

Mek Inhibitors, Virus Infection, Medicine +6